| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
EyeGate Pharmaceuticals Inc (NASDAQ: EYEG)
EYEG Technical Analysis
5
| As on 7th Jan 2022 EYEG STOCK Price closed @ 1.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.29 & Strong Sell for SHORT-TERM with Stoploss of 3.61 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EYEGSTOCK Price
| Open | 0.98 | Change | Price | % |
| High | 1.06 | 1 Day | -0.03 | -2.91 |
| Low | 0.98 | 1 Week | 0.12 | 13.64 |
| Close | 1.00 | 1 Month | -0.51 | -33.77 |
| Volume | 452859 | 1 Year | -2.82 | -73.82 |
| 52 Week High 7.68 | 52 Week Low 0.86 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| EYEG Daily Charts |
EYEG Intraday Charts |
Whats New @ Bazaartrend |
EYEG Free Analysis |
|
|
EYEG Important Levels Intraday
| RESISTANCE | 1.15 |
| RESISTANCE | 1.10 |
| RESISTANCE | 1.07 |
| RESISTANCE | 1.04 |
| SUPPORT | 0.96 |
| SUPPORT | 0.93 |
| SUPPORT | 0.90 |
| SUPPORT | 0.85 |
EYEG Forecast May 2024
| 4th UP Forecast | 2.43 |
| 3rd UP Forecast | 1.97 |
| 2nd UP Forecast | 1.69 |
| 1st UP Forecast | 1.4 |
| 1st DOWN Forecast | 0.6 |
| 2nd DOWN Forecast | 0.31 |
| 3rd DOWN Forecast | 0.03 |
| 4th DOWN Forecast | -0.43 |
EYEG Weekly Forecast
| 4th UP Forecast | 1.60 |
| 3rd UP Forecast | 1.41 |
| 2nd UP Forecast | 1.29 |
| 1st UP Forecast | 1.17 |
| 1st DOWN Forecast | 0.83 |
| 2nd DOWN Forecast | 0.71 |
| 3rd DOWN Forecast | 0.59 |
| 4th DOWN Forecast | 0.40 |
EYEG Forecast2024
| 4th UP Forecast | 15.22 |
| 3rd UP Forecast | 10.66 |
| 2nd UP Forecast | 7.84 |
| 1st UP Forecast | 5.02 |
| 1st DOWN Forecast | -3.02 |
| 2nd DOWN Forecast | -5.84 |
| 3rd DOWN Forecast | -8.66 |
| 4th DOWN Forecast | -13.22 |
EyeGate Pharmaceuticals Inc ( NASDAQ USA Symbol : EYEG )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EYEG Business Profile
EyeGate Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system in the United States. It develops PP-001, a clinical stage dihydroorotate dehydrogenase inhibitor that has been developed in two clinical-stage ophthalmic formulations, consisting of PaniJect that is in Phase Ia/IIb clinical trial for multiple diseases that affect the posterior region of the eye, including non-infectious posterior uveitis and diabetic macular edema; and PaniDrop, which is in Phase I safety study for multiple diseases that affect the ocular surface and anterior region of the eye, comprising of allergic conjunctivitis, viral conjunctivitis, and dry eye disease. The company also develops ocular bandage gel, a modified form of the natural polymer hyaluronic acid for corneal wound repair, and punctate epitheliopathies with a focus on dry eye. The company has license agreements with BioTime, Inc. Eyegate Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Waltham, Massachusetts. Address: 271 Waverley Oaks Road, Waltham, MA, United States, 02452
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service